Grantham, Mayo, Van Otterloo & Co (GMO)
OME

Grantham, Mayo, Van Otterloo & Co (GMO)’s Omega Protein OME Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio OME Stock Details OME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-17,500
Closed -$291K – 656
2017
Q3 		$291K Sell
17,500
-3,400
-16% -$55.3K ﹤0.01% 487
2017
Q2 		$374K Hold
20,900
– – ﹤0.01% 439
2017
Q1 		$419K Sell
20,900
-16,070
-43% -$374K ﹤0.01% 411
2016
Q4 		$926K Sell
36,970
-96,577
-72% -$2.28M 0.01% 379
2016
Q3 		$3.12M Sell
133,547
-94,953
-42% -$2.23M 0.01% 292
2016
Q2 		$4.57M Buy
228,500
+198,100
+652% +$3.7M 0.02% 299
2016
Q1 		$515K Buy
+30,400
New +$623K ﹤0.01% 459

Grantham, Mayo, Van Otterloo & Co (GMO)'s OME Position: Q4 2017 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Omega Protein (OME) in Q4 2017, closing a stake of 17,500 shares — an estimated $291K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in OME in Q1 2016 and held it in 7 quarters. The position peaked at $4.57M in Q2 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 17,500 Omega Protein shares in Q4 2017, an estimated $291K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Omega Protein in Q1 2016 and held it in 7 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Omega Protein position peaked at $4.57M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2017, filed 14 Feb 2018.